scispace - formally typeset
H

Huimei An

Researcher at Peking University

Publications -  21
Citations -  244

Huimei An is an academic researcher from Peking University. The author has contributed to research in topics: Positive and Negative Syndrome Scale & Medicine. The author has an hindex of 6, co-authored 16 publications receiving 132 citations.

Papers
More filters
Journal ArticleDOI

Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients

TL;DR: The results suggested that oxidative stress may play an important role in antipsychotic-induced weight gain and further investigations using the longitudinal design in first-episode schizophrenia patients are needed to explore the beneficial effect of antioxidants on the abnormal lipid metabolism mediated by antipsychotics.
Journal ArticleDOI

Glucose disturbances in first-episode drug-naïve schizophrenia: relationship to psychopathology

TL;DR: Examination of glucose and lipid metabolism in first-episode and drug naïve patients with schizophrenia and their relationships with psychopathology suggest abnormal glucose metabolism may be associated with the pathogenesis and psychopathology of schizophrenia in the early phases of the disease process.
Journal ArticleDOI

Gut Microbiome Composition Associated With Major Depressive Disorder and Sleep Quality

TL;DR: In this paper, the authors performed 16S rRNA sequencing of stool samples from 36 patients with major depressive disorder and 45 healthy controls (HC) and found that six microbiota targets were associated with the severity of depression, 11 with sleep quality, and 3 with sleep severity.
Journal ArticleDOI

Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.

TL;DR: Elevated levels of NMDar antibody may play a role in the pathogenesis of schizophrenia, leading to NMDAR dysfunction, thereby inducing symptoms of psychosis and cognitive impairment, and may serve as a biomarker and provide a new avenue for treatment of schizophrenia.
Journal ArticleDOI

Plasma total antioxidant status and cognitive impairments in first-episode drug-naïve patients with schizophrenia.

TL;DR: The results suggested that oxidative stress may be involved in the pathophysiology of schizophrenia at the early of stage and its cognitive impairment.